WAM
CNMD icon

Wealthspire Advisors (Maryland)’s CONMED CNMD Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-60
Closed -$5K – 763
2019
Q1 		$5K Hold
60
– – ﹤0.01% 1806
2018
Q4 		$4K Buy
60
+8
+15% +$547 ﹤0.01% 1796
2018
Q3 		$4K Buy
52
+26
+100% +$2.01K ﹤0.01% 1882
2018
Q2 		$2K Hold
26
– – ﹤0.01% 2132
2018
Q1 		$2K Hold
26
– – ﹤0.01% 2145
2017
Q4 		$1K Buy
26
+24
+1,200% +$1.25K ﹤0.01% 2251
2017
Q3 		$0 Buy
+2
New +$100 ﹤0.01% 2280

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s CNMD Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of CONMED (CNMD) in Q2 2019, closing a stake of 60 shares — an estimated $5K sold.

Wealthspire Advisors (Maryland) first reported a position in CNMD in Q3 2017 and held it in 7 quarters. The position peaked at $5K in Q1 2019. 230 funds tracked by Wall St. Rank hold CNMD as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining CONMED position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 60 CONMED shares in Q2 2019, an estimated $5K.
  • Wealthspire Advisors (Maryland) first reported a position in CONMED in Q3 2017 and held it in 7 quarters.
  • Wealthspire Advisors (Maryland)'s CONMED position peaked at $5K in Q1 2019.
  • 230 funds tracked by Wall St. Rank held CONMED as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.